Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

KIR3DL1 Antibody (MM0443-1L34), DyLight 550, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NBP211763R

Catalog No. NBP211763R


Only null left
Add to Cart

Description

Description

KIR3DL1 Monoclonal specifically detects KIR3DL1 in Human samples. It is validated for Flow Cytometry.
Specifications

Specifications

KIR3DL1
Monoclonal
DyLight 550
50mM Sodium Borate with 0.05% Sodium Azide
KIR3DL1
Human recombinant KIR3DL1
0.1 mL
Primary
This antibody was selected for its ability to specifically detect human KIR3DL1.
Store at 4C in the dark.
IgG1
Flow Cytometry
MM0443-1L34
Flow Cytometry
AMB11, CD158 antigen-like family member E, CD158E, CD158e antigen, CD158e1, CD158e1/2, CD158e2, cl-11, cl-2, HLA-BW4-specific inhibitory NK cell receptor, killer cell immunoglobulin-like receptor 3DL1, killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail1,nkat3, killer Ig receptor, KIR antigen 3DL1, KIR3DL1/S1, KIR3DS1, MGC119726, MGC119728, MGC126589, MGC126591, MHC class I NK cell receptor, Natural killer-associated transcript 3, NKAT-3, NKAT3KIR, NKB1B, NKB1CD158E1, NK-receptor, p70 killer cell inhibitory receptor, p70 natural killer cell receptor clones CL-2/CL-11, p70 NK receptor CL-2/CL-11
Mouse
Protein G purified
Immunology
3811
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.